Literature DB >> 28409538

Prevalence and predictors of severe menopause symptoms among HIV-positive and -negative Nigerian women.

Patricia A Agaba1,2, Seema T Meloni3, Halima M Sule1,2, Amaka N Ocheke4, Emmanuel I Agaba5, John A Idoko6, Phyllis J Kanki3.   

Abstract

We compared the prevalence of menopause symptoms between women living with HIV to their HIV-negative peers and determined predictors of severe menopause symptoms in Jos, Nigeria. This descriptive cross-sectional study included 714 women aged 40-80 years. We compared prevalence and severity of menopause symptoms using the menopause rating scale (MRS). Logistic regression analysis was used to determine the predictors of severe symptoms. Six-hundred and seven (85.0%) were HIV-positive, with a mean duration of infection of 5.6 ± 2.7 years. The mean age of the cohort was 46 ± 5 years. The most prevalent menopause symptoms were hot flushes (67.2%), joint and muscle discomfort (66.2%), physical/mental exhaustion (65.3%), heart discomfort (60.4%), and anxiety (56.4%). The median MRS score was higher for HIV-positive compared to HIV-negative women (p = 0.01). Factors associated with severe menopause symptoms included HIV-positive status (aOR: 3.01, 95% CI: 1.20-7.54) and history of cigarette smoking (aOR: 4.18, 95% CI: 1.31-13.26). Being married (aOR: 0.49, 95% CI: 0.32-0.77), premenopausal (aOR: 0.60, 95% CI: 0.39-0.94), and self-reporting good quality of life (aOR: 0.62. 95% CI: 0.39-0.98) were protective against severe menopause symptoms. We found HIV infection, cigarette smoking, quality of life, and stage of the menopause transition to be associated with severe menopause symptoms. As HIV-positive populations are aging, additional attention should be given to the reproductive health of these women.

Entities:  

Keywords:  AIDS; Africa; HIV; menopause; women

Mesh:

Year:  2017        PMID: 28409538     DOI: 10.1177/0956462417704778

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  5 in total

1.  Hormone therapy and fractures in postmenopausal women.

Authors:  Michael T Yin; Donald R Hoover; Qiuhu Shi; Phyllis C Tien; Mardge H Cohen; Seble Kassaye; Deborah Gustafson; Adaora Adimora; M Neale Weitzmann; Hector Bolivar; Amy Warriner; Sara H Bares; Anjali Sharma
Journal:  AIDS       Date:  2022-06-22       Impact factor: 4.632

2.  Brief Report: Undercarboxylated Osteocalcin Is Associated With Cognition in Women With and Without HIV.

Authors:  Ryan D Ross; Arnold Z Olali; Qiuhu Shi; Donald R Hoover; Anjali Sharma; Kathleen M Weber; Audrey L French; Heather McKay; Phyllis C Tien; Michael T Yin; Leah H Rubin
Journal:  J Acquir Immune Defic Syndr       Date:  2022-10-01       Impact factor: 3.771

Review 3.  Correlates of palpitations during menopause: A scoping review.

Authors:  Janet S Carpenter; Ying Sheng; Caitlin Pike; Charles D Elomba; Jennifer S Alwine; Chen X Chen; James E Tisdale
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

Review 4.  Review of menopausal palpitations measures.

Authors:  Ying Sheng; Janet S Carpenter; Charles D Elomba; Jennifer S Alwine; Min Yue; Caitlin A Pike; Chen X Chen; James E Tisdale
Journal:  Womens Midlife Health       Date:  2021-05-31

5.  The Prevalence and Patterns of Menopausal Symptoms in Women Living with HIV.

Authors:  H Okhai; C Sabin; K Haag; L Sherr; R Dhairyawan; J Shephard; G Richard; F Burns; F Post; R Jones; Y Gilleece; S Tariq
Journal:  AIDS Behav       Date:  2022-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.